| Predicted Trait | |
| Reported Trait | Skin cutaneous melanoma |
| Mapped Trait(s) | cutaneous melanoma (EFO_0000389) |
| Score Construction | |
| PGS Name | best_SKCM |
| Development Method | |
| Name | Pruning and Thresholding (P+T) |
| Parameters | p < 1×10^-4, r2 < 0.1 |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 672 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000413 |
| Citation (link to publication) | Namba S et al. Cancer Res (2022) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 111,549 individuals (100%) |
| PGS Evaluation | European: 100% 1 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
Europe PMC: 10.1038/s41588-020-0611-8 |
[
|
European | NR |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM016257 | PSS010085| European Ancestry| 273,786 individuals |
PGP000413 | Namba S et al. Cancer Res (2022) |
Reported Trait: skin cutaneous melanoma | — | AUROC: 0.682 | R²: 0.0261 | age, sex, top 20 genetic principal components | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS010085 | C43 | — | [
|
— | European (British) |
— | UKB | Controls were samples without any cancer diagnosis or self-reported cancer |